S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NYSE:SG

Sweetgreen (SG) Stock Price, News & Analysis

$20.65
-0.19 (-0.91%)
(As of 04/19/2024 ET)
Today's Range
$20.41
$21.24
50-Day Range
$11.24
$25.60
52-Week Range
$7.25
$26.45
Volume
1.41 million shs
Average Volume
1.76 million shs
Market Capitalization
$2.33 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.50

Sweetgreen MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
0.7% Downside
$20.50 Price Target
Short Interest
Healthy
10.86% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.63mentions of Sweetgreen in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$2.27 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.71) to ($0.52) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.91 out of 5 stars

Retail/Wholesale Sector

151st out of 201 stocks

Eating Places Industry

36th out of 41 stocks

SG stock logo

About Sweetgreen Stock (NYSE:SG)

Sweetgreen, Inc., together with its subsidiaries, operates fast food restaurants serving healthy foods at scale in the United States. The company also accepts orders through its online and mobile ordering platforms, as well as sells gift cards that do not have an expiration date and can be redeemed. The company was founded in 2006 and is headquartered in Los Angeles, California.

SG Stock Price History

SG Stock News Headlines

Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Sweetgreen (NYSE:SG) Given "Hold" Rating at TD Cowen
Sweetgreen (NYSE:SG) Stock Rating Reaffirmed by TD Cowen
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
The 3 Best Russell 2000 Stocks to Buy in April 2024
11 Analysts Assess Sweetgreen: What You Need To Know
Sweetgreen: 2 Key Strategies To Drive Growth Ahead
Sweetgreen, Inc. (SG)
2 Stocks That Can Double Again in 2024
The America That Runs on Sweetgreen
First Week of SG May 17th Options Trading
Validea Detailed Fundamental Analysis - SG
See More Headlines
Receive SG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sweetgreen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
4/21/2024
Next Earnings (Confirmed)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Eating places
Sub-Industry
N/A
Fax
N/A
Employees
6,186
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.50
High Stock Price Target
$34.00
Low Stock Price Target
$13.00
Potential Upside/Downside
-0.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

Net Income
$-113,380,000.00
Pretax Margin
-19.35%

Debt

Sales & Book Value

Annual Sales
$584.04 million
Book Value
$4.28 per share

Miscellaneous

Free Float
88,091,000
Market Cap
$2.33 billion
Optionable
Optionable
Beta
2.20
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Jonathan Neman (Age 38)
    Co-Founder, Chairman, President & CEO
    Comp: $350.14k
  • Mr. Nicolas H. Jammet (Age 38)
    Co-Founder, Secretary, Chief Concept Officer & Director
  • Mr. Nathaniel Ru (Age 38)
    Co-Founder, Treasurer, Chief Brand Officer & Director
  • Mr. Mitch Reback (Age 69)
    Chief Financial Officer
    Comp: $375.14k
  • Ms. Wouleta Ayele (Age 58)
    Chief Technology Officer
    Comp: $554.72k
  • Ms. Rossann Williams
    Chief Operating Officer
  • Rebecca Nounou
    Head of Investor Relations
  • Mr. Michael Kotick
    VP & Head of Marketing
  • Ms. Adrienne Gemperle (Age 59)
    Chief People Officer
  • Mr. Chad Brauze
    Head of Culinary

SG Stock Analysis - Frequently Asked Questions

Should I buy or sell Sweetgreen stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sweetgreen in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SG shares.
View SG analyst ratings
or view top-rated stocks.

What is Sweetgreen's stock price target for 2024?

8 brokers have issued twelve-month target prices for Sweetgreen's stock. Their SG share price targets range from $13.00 to $34.00. On average, they predict the company's stock price to reach $20.50 in the next twelve months. This suggests that the stock has a possible downside of 0.7%.
View analysts price targets for SG
or view top-rated stocks among Wall Street analysts.

How have SG shares performed in 2024?

Sweetgreen's stock was trading at $11.30 at the start of the year. Since then, SG shares have increased by 82.7% and is now trading at $20.65.
View the best growth stocks for 2024 here
.

When is Sweetgreen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our SG earnings forecast
.

How can I listen to Sweetgreen's earnings call?

Sweetgreen will be holding an earnings conference call on Thursday, May 9th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Sweetgreen's earnings last quarter?

Sweetgreen, Inc. (NYSE:SG) posted its quarterly earnings data on Thursday, February, 29th. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.23) by $0.01. The company earned $153 million during the quarter, compared to analysts' expectations of $152.04 million. Sweetgreen had a negative net margin of 19.41% and a negative trailing twelve-month return on equity of 21.58%. Sweetgreen's revenue for the quarter was up 29.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.44) earnings per share.

What ETF holds Sweetgreen's stock?

Invesco Dorsey Wright Consumer Cyclicals Momentum ETF holds 39,796 shares of SG stock, representing 1.56% of its portfolio.

What guidance has Sweetgreen issued on next quarter's earnings?

Sweetgreen issued an update on its FY 2024 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $655.0 million-$670.0 million, compared to the consensus revenue estimate of $661.5 million.

What other stocks do shareholders of Sweetgreen own?
When did Sweetgreen IPO?

Sweetgreen (SG) raised $312 million in an IPO on Thursday, November 18th 2021. The company issued 13,000,000 shares at $23.00-$25.00 per share.

Who are Sweetgreen's major shareholders?

Sweetgreen's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Artemis Investment Management LLP (0.53%), Curated Wealth Partners LLC (0.00%), Optas LLC (0.01%) and Counterpoint Mutual Funds LLC (0.01%). Insiders that own company stock include Adrienne Gemperle, Chris Carr, Daniel Shlossman, James Mcphail, Jonathan Neman, Mitch Reback, Nathaniel Ru, Nicolas Jammet and Wouleta Ayele.
View institutional ownership trends
.

How do I buy shares of Sweetgreen?

Shares of SG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SG) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners